Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study
Growth arrest-specific gene 6 protein (Gas6) is avitamin K-dependent tissue bound protein. Gas6 has been shown to promote growth and therapy resistance among different types of cancer as well as thromboembolism. The aim of this prospective screening study: ClinicalTrials.gov; Identifier: NTC3782025,...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6cb86dea8f2f4edf95dff760a8cec8be |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6cb86dea8f2f4edf95dff760a8cec8be |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6cb86dea8f2f4edf95dff760a8cec8be2021-11-25T18:36:45ZVitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study10.3390/nu131141012072-6643https://doaj.org/article/6cb86dea8f2f4edf95dff760a8cec8be2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/4101https://doaj.org/toc/2072-6643Growth arrest-specific gene 6 protein (Gas6) is avitamin K-dependent tissue bound protein. Gas6 has been shown to promote growth and therapy resistance among different types of cancer as well as thromboembolism. The aim of this prospective screening study: ClinicalTrials.gov; Identifier: NTC3782025, was to evaluate the effects of intravenously administered vitamin K1 on Gas6 and its soluble (s)Axl receptor plasma levels in intensive care patients. Vitamin K1 was intravenously injected in non-warfarin treated patients with prolonged Owren prothrombin time international normalized ratio (PT-INR) > 1.2 and blood samples were retrieved before and 20–28 h after injection. Citrate plasma samples from 52 intensive care patients were analysed for different vitamin K dependent proteins. There was a significant, but small increase in median Gas6. Only one patient had a large increase in sAxl, but overall, no significant changes in sAxl Gas6 did not correlate to PT-INR, thrombin generation assay, coagulation factors II, VII, IX and X, but to protein S and decarboxylated matrix Gla protein (dp-ucMGP). In conclusion, there was a small increase in Gas6 over 20–28 h. The pathophysiology and clinical importance of this remains to be investigated. To verify a true vitamin K effect, improvement of Gas6 carboxylation defects needs to be studied.Ulf SchöttCecilia AugustssonLuukas LiloverCaroline Ulfsdotter NilssonLouise Walther-SturessonThomas KanderMDPI AGarticleGas6Axl receptorendothelial dysfunctionprothrombin timeGla proteinthrombin generationNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 4101, p 4101 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Gas6 Axl receptor endothelial dysfunction prothrombin time Gla protein thrombin generation Nutrition. Foods and food supply TX341-641 |
| spellingShingle |
Gas6 Axl receptor endothelial dysfunction prothrombin time Gla protein thrombin generation Nutrition. Foods and food supply TX341-641 Ulf Schött Cecilia Augustsson Luukas Lilover Caroline Ulfsdotter Nilsson Louise Walther-Sturesson Thomas Kander Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study |
| description |
Growth arrest-specific gene 6 protein (Gas6) is avitamin K-dependent tissue bound protein. Gas6 has been shown to promote growth and therapy resistance among different types of cancer as well as thromboembolism. The aim of this prospective screening study: ClinicalTrials.gov; Identifier: NTC3782025, was to evaluate the effects of intravenously administered vitamin K1 on Gas6 and its soluble (s)Axl receptor plasma levels in intensive care patients. Vitamin K1 was intravenously injected in non-warfarin treated patients with prolonged Owren prothrombin time international normalized ratio (PT-INR) > 1.2 and blood samples were retrieved before and 20–28 h after injection. Citrate plasma samples from 52 intensive care patients were analysed for different vitamin K dependent proteins. There was a significant, but small increase in median Gas6. Only one patient had a large increase in sAxl, but overall, no significant changes in sAxl Gas6 did not correlate to PT-INR, thrombin generation assay, coagulation factors II, VII, IX and X, but to protein S and decarboxylated matrix Gla protein (dp-ucMGP). In conclusion, there was a small increase in Gas6 over 20–28 h. The pathophysiology and clinical importance of this remains to be investigated. To verify a true vitamin K effect, improvement of Gas6 carboxylation defects needs to be studied. |
| format |
article |
| author |
Ulf Schött Cecilia Augustsson Luukas Lilover Caroline Ulfsdotter Nilsson Louise Walther-Sturesson Thomas Kander |
| author_facet |
Ulf Schött Cecilia Augustsson Luukas Lilover Caroline Ulfsdotter Nilsson Louise Walther-Sturesson Thomas Kander |
| author_sort |
Ulf Schött |
| title |
Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study |
| title_short |
Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study |
| title_full |
Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study |
| title_fullStr |
Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study |
| title_full_unstemmed |
Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study |
| title_sort |
vitamin k effects on gas6 and soluble axl receptors in intensive care patients: an observational screening study |
| publisher |
MDPI AG |
| publishDate |
2021 |
| url |
https://doaj.org/article/6cb86dea8f2f4edf95dff760a8cec8be |
| work_keys_str_mv |
AT ulfschott vitaminkeffectsongas6andsolubleaxlreceptorsinintensivecarepatientsanobservationalscreeningstudy AT ceciliaaugustsson vitaminkeffectsongas6andsolubleaxlreceptorsinintensivecarepatientsanobservationalscreeningstudy AT luukaslilover vitaminkeffectsongas6andsolubleaxlreceptorsinintensivecarepatientsanobservationalscreeningstudy AT carolineulfsdotternilsson vitaminkeffectsongas6andsolubleaxlreceptorsinintensivecarepatientsanobservationalscreeningstudy AT louisewalthersturesson vitaminkeffectsongas6andsolubleaxlreceptorsinintensivecarepatientsanobservationalscreeningstudy AT thomaskander vitaminkeffectsongas6andsolubleaxlreceptorsinintensivecarepatientsanobservationalscreeningstudy |
| _version_ |
1718410896445800448 |